Back to compounds

COMPOUND PROFILE / SMALL MOLECULES

5-Amino-1MQ.

Research draft

5-Amino-1MQ is an experimental small-molecule NNMT inhibitor.

Keep the context.

Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.

Targeted source and identity review, not a systematic review or complete regulatory audit.

Overview

5-Amino-1MQ is an experimental small-molecule NNMT inhibitor.

CLASSIFICATIONSmall molecules
MOLECULAR / SEQUENCE INFOSmall molecule (quinolinium)
PRIMARY CONTEXTNNMT inhibitor (research)

Mechanism

It inhibits nicotinamide N-methyltransferase, affecting metabolic pathways in experimental models.

Human research

A credible therapeutic human evidence base was not established.

Preclinical & other research

Mouse obesity experiments reported metabolic effects; these cannot establish human fat loss.

Safety & unknowns

Human pharmacokinetics, adverse effects and long-term consequences remain unresolved.

Regulatory status

Research compound; not a peptide or established weight-loss medicine.

Reported use & evidence

Research profile draft

The supplied 5-Amino-1MQ profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.

Sources & references

Explore more compounds